There are two types of macular degeneration: dry (non-exudative) and wet (exudative). Dry AMD causes a more gradual loss of ...

Since these landmark trials, physicians have tried several different treatment regimens to determine the optimal treatment plan for patients with exudative AMD. These alternative dosing regimens ...

As people age, some can develop age-related macular degeneration, or AMD, meaning they struggle with or lose their central vision. While there is no cure, AMD can be treated and does not typically ...

Announces several updates to enhance and accelerate AXPAXLI registrational program in wet AMD, potentially supporting label flexibility of 6-12 months to showcase expected best-in-class durability FDA ...

announced positive initial interim 52-week data from the Phase 2b Population Extension cohort of the PRISM clinical trial evaluating 4D-150 in a broad wet age-related macular degeneration (wet AMD ...

The study included patients who had been on long-term ranibizumab for the treatment of wet AMD and had switched to intravitreal aflibercept injection. Inclusion criteria were as follows ...